Streptococcus pseudopneumoniae, an opportunistic pathogen in patients with cystic fibrosis

被引:13
|
作者
Dupont, Chloe [1 ]
Michon, Anne-Laure [2 ]
Normandin, Marion [3 ]
Salom, Guillaume [3 ]
Latypov, Marie [4 ]
Chiron, Raphael [5 ]
Marchandin, Helene [6 ]
机构
[1] Univ Montpellier, HydroSci Montpellier, Lab Ecol Microbienne Hosp, Montpellier Univ Hosp,IRD,CNRS, Montpellier, France
[2] Montpellier Univ Hosp, Lab Bacteriol, Montpellier, France
[3] Univ Montpellier, CNRS, HydroSci Montpellier, IRD, Montpellier, France
[4] Montpellier Univ Hosp, Ctr Ressources & Competences Mucoviscidose, Montpellier, France
[5] Univ Montpellier, HydroSci Montpellier, Ctr Ressources & Competences Mucoviscidose, Montpellier Univ Hosp,CNRS,IRD, Montpellier, France
[6] Univ Montpellier, Nimes Univ Hosp, Dept Microbiol, HydroSci Montpellier,CNRS,IRD, Nimes, France
关键词
Cystic fibrosis; Streptococcus pseudopneumoniae; Opportunistic pathogen; Exacerbation; Identification; Resistance; PNEUMONIAE; RESISTANCE;
D O I
10.1016/j.jcf.2019.11.004
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The pathogenic power of Streptococcus pseudopneumoniae has been specified over years, particularly in case of chronic respiratory diseases; S. pseudopneumoniae isolation has however not been characterized before in CF patients. Identification of S. pseudopneumoniae remains challenging due to the high similarity level between species of the Streptococcus mitis group. Twenty CF patients with S. pseudopneumoniae were included. Isolates initially identified by phenotypic routine methods were subjected to both recA sequencing and amplification of S. pseudopneumoniae specific markers. Microbiological and clinical data were reviewed for patients with confirmed S. pseudopneumoniae. Thirteen isolates actually belong to S. pseudopneumoniae. S. pseudopneumoniae was associated with pulmonary exacerbation in 46% of the patients, either as the sole pathogen or as part of a polymicrobial infectious process. S. pseudopneumoniae has to be considered as an additional opportunistic pathogen in CF and additional studies are needed to increase knowledge of its epidemiology and clinical significance in CF. (C) 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:E28 / E31
页数:4
相关论文
共 50 条
  • [31] First report of cystic fibrosis mutations in Libyan cystic fibrosis patients
    Fredj, Sondess Hadj
    Fattoum, Slaheddine
    Chabchoub, Abdelraouf
    Messaoud, Taieb
    ANNALS OF HUMAN BIOLOGY, 2011, 38 (05) : 561 - 563
  • [32] The phosphatome of opportunistic pathogen Candida species
    Szabo, Krisztina
    Miskei, Marton
    Farkas, Ilona
    Dombradi, Viktor
    FUNGAL BIOLOGY REVIEWS, 2021, 35 : 40 - 51
  • [33] Clinical outcomes for cystic fibrosis patients with Pseudomonas aeruginosa cross-infections
    Milczewska, Justyna
    Wolkowicz, Tomasz
    Zacharczuk, Katarzyna
    Mierzejewska, Ewa
    Kwiatkowska, Monika
    Walicka-Serzysko, Katarzyna
    Sands, Dorota
    PEDIATRIC PULMONOLOGY, 2020, 55 (01) : 161 - 168
  • [34] What is the role of Achromobacter species in patients with cystic fibrosis?
    Esposito, Susanna
    Pisi, Giovanna
    Fainardi, Valentina
    Principi, Nicola
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2021, 26 (12): : 1613 - 1620
  • [35] Susceptibility of Candida albicans from Cystic Fibrosis Patients
    Sabino, Raquel
    Carolino, Elisabete
    Moss, Richard B.
    Banaei, Niaz
    Verissimo, Cristina
    Stevens, David A.
    MYCOPATHOLOGIA, 2017, 182 (9-10) : 863 - 867
  • [36] First isolations in India of Candida nivariensis, a globally emerging opportunistic pathogen
    Chowdhary, Anuradha
    Randhawa, H. S.
    Khan, Z. U.
    Ahmad, S.
    Juneja, S.
    Sharma, B.
    Roy, P.
    Sundar, G.
    Joseph, L.
    MEDICAL MYCOLOGY, 2010, 48 (02) : 416 - 420
  • [37] Investigation of role of anaerobic bacteria in cystic fibrosis patients
    Dogan, Ozlem
    Tunckanat, Ferda
    Cinel, Guzin
    Sener, Burcin
    Ozcelik, H. Ugur
    Yalcin, Elmas Ebru
    Ersoz, Deniz Dogru
    Kiper, E. Nural
    TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2019, 67 (03): : 151 - 161
  • [38] Clinical and Antimicrobial Susceptibility Data of 140 Streptococcus pseudopneumoniae Isolates in France
    Laurens, C.
    Michon, A. -L.
    Marchandin, H.
    Bayette, J.
    Didelot, M. -N.
    Jean-Pierre, H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (08) : 4504 - 4507
  • [39] Late-onset bleb-related endophthalmitis caused by Streptococcus pseudopneumoniae
    Kawakami, Hideaki
    Nakane, Yuko
    Inuzuka, Hiroko
    Fukagawa, Tominori
    Muto, Toshihiro
    Mochizuki, Kiyofumi
    Ohkusu, Kiyofumi
    Suematsu, Hiroyuki
    Yamagishi, Yuka
    Mikamo, Hiroshige
    INTERNATIONAL OPHTHALMOLOGY, 2014, 34 (03) : 643 - 646
  • [40] Aspergillus Bronchitis in Patients with Cystic Fibrosis
    Brandt, Claudia
    Roehmel, Jobst
    Rickerts, Volker
    Melichar, Volker
    Niemann, Nadja
    Schwarz, Carsten
    MYCOPATHOLOGIA, 2018, 183 (01) : 61 - 69